Latest Health News
World Chagas Disease Day 2026 Highlights Women's Role in Elimination
PAHO and the Global Chagas Coalition emphasize women's central role in early detection, prevention, and care for Chagas disease on April 14. Approximately 7.5 million people are infected in the Americas, with 30,000 new cases and 10,000 deaths yearly, including 9,000 congenital cases.
Strengthening maternal health screening is key to breaking transmission cycles.
WHO Webinar Addresses Cholera in Humanitarian Settings
WHO's EPI-WIN webinar on April 15 discusses cholera's resurgence, affecting 1.3-4 million cases and 21,000-143,000 deaths annually, hitting fragile areas hardest. Humanitarian crises exacerbate outbreaks due to poor WASH, displacement, and limited healthcare.
Community and CSO involvement is vital for prevention under the 2030 Roadmap.
CSIS Futures Summit Tackles Post-2025 Global Health Shifts
CSIS event on April 14 reviews 2025's 20-40% drop in health aid from major donors, reshaping landscapes amid geopolitical tensions. Leaders from CEPI, Africa CDC, and Wellcome Trust discuss funding pivots, post-COVID priorities, and AI-driven innovations.
Chronic and infectious threats challenge progress.
Johns Hopkins Hosts Health and Social Policy Seminar
Institute for Health and Social Policy Annual Seminar occurs today, April 14, focusing on health policy intersections. Event runs 12:00-1:00 p.m. ET at Wolfe Street Building.
Aims to advance policy discussions in social determinants.
World Hemophilia Day 2026 Targets Diagnosis Gaps
WFH's April 17 event pushes to close care gaps, with over 75% of hemophilia cases undiagnosed globally. Focuses on training professionals and labs for 'Treatment for All'.
Honors founder Frank Schnabel's legacy in bleeding disorder advocacy.
New siRNA Therapy Qfitlia Approved for Hemophilia
Sanofi's Qfitlia (fitusiran), FDA-approved in March 2025, reduces bleeding rates via antithrombin reduction in Phase III trials. Marks a first-in-class alternative to factor therapies.
Advances treatment era for bleeding disorders.
Novo Nordisk Expands Alhemo for Broader Hemophilia Use
Alhemo (concizumab) label expanded in 2025 to non-inhibitor patients, offering once-daily prophylaxis. Enhances options for hemophilia A and B management.
Supports World Hemophilia Day's innovation push.
Chagas Disease Poses $500 Million Annual Economic Burden
PAHO reports 770,000 DALYs lost yearly from Chagas in 21 endemic Americas countries. Migration boosts non-vector transmission risks, especially congenital.
Calls for integrated primary care and policies.
Global Cholera Resurgence Signals Inequity Indicator
Outbreaks concentrate in crisis contexts with higher fatality rates, per WHO data. Adaptive strategies needed beyond conventional methods in emergencies.
Aligns with ending cholera by 2030 goals.
PAHO Urges Timely Access for Reproductive-Age Women
Dr. Jarbas Barbosa stresses screening in maternal services to eliminate congenital Chagas. 2-8% transmission rate from infected mothers.
Avoids overburdening women, promotes equitable systems.
Global Health Leaders Eye AI and Drug Breakthroughs
CSIS panel highlights AI for delivery and new discoveries amid funding cuts. U.S. shifts to bilateral aid; Global South pushes sovereignty.
Addresses biological threats post-COVID.